Castor oil polymer induces bone formation with high matrix metalloproteinase-2 expression

Current research explores how synthetic materials can influence bone growth and remodeling. Established knowledge shows that matrix metalloproteinases (MMPs) regulate extracellular matrix turnover. However, the specific role of MMP-2 and MMP-9 in bone regeneration remains unclear. This gap motivated researchers to investigate how castor oil-derived polymers affect bone formation. Prior studies have linked MMP-2 to tissue remodeling and wound healing processes. Yet, the connection between polymer-based implants and MMP modulation is not fully understood. This uncertainty drove the need to examine the interface between polymer implants and bone tissue. Such investigations could help develop better biomaterials for orthopedic applications.

The study aimed to evaluate how a polymer derived from castor oil affects bone formation. Specifically, the researchers focused on the expression of MMP-2 and MMP-9 at the implant-bone interface. They hypothesized that the polymer might influence bone remodeling through MMP regulation. The study also sought to compare the bone formation process in the polymer group versus the control. By analyzing tissue density and osteocyte distribution, the team aimed to assess new bone growth. The goal was to determine if the polymer could stimulate bone maturation and remodeling. The researchers also wanted to observe how long the newly formed bone tissue continued to mature. This approach could provide insights into biomaterials that support bone regeneration.

The study used 44 rabbits divided into two groups: a control group and a polymer-implanted group. In the polymer group, the tibial medullary canals were reamed and filled with castor oil polymer. CT scans were used to assess the interface between the polymer and surrounding bone tissue. Tissue density measurements were taken to compare the polymer-bone interface with other bone regions. Histological analysis was performed at 90, 120, and 150 days post-implantation to evaluate bone maturation. MMP-2 and MMP-9 expression levels were analyzed to determine their role in the remodeling process. The control group received no polymer implant and served as a baseline for comparison. The study tracked the progression of bone tissue formation and osteocyte distribution over time.

At 90 days post-implantation, the polymer-bone interface showed a thick layer of newly formed bone tissue. This tissue was rich in osteocytes and exhibited ongoing maturation at 120 and 150 days. The newly formed bone tissue had a density similar to other regions of the tibia. MMP-2 expression was positively modulated in the polymer group compared to the control. MMP-9 levels remained low in the polymer group, suggesting limited extracellular matrix degradation. In the control group, the internal medullary surface was lined by osteoblasts with few osteocytes. The control tissue showed nonlamellar bone structure, indicating less mature bone formation. These findings suggest the polymer supports bone remodeling through MMP-2 upregulation.

The study found that the castor oil polymer supports new bone formation at the implant-bone interface. The observed bone maturation was accompanied by increased MMP-2 expression and low MMP-9 activity. These results suggest that the polymer modulates bone remodeling through MMP regulation. The newly formed bone tissue was rich in osteocytes and showed progressive maturation over time. In contrast, the control group exhibited less mature bone structure with fewer osteocytes. The polymer-bone interface showed no gaps, indicating good integration between the material and tissue. These findings align with the authors' hypothesis that the polymer promotes bone formation. The study highlights the potential of castor oil-based polymers in orthopedic biomaterials.